Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1 Endometrial Hyperplasia 1

Interventions

Cyclophosphamide 2067 Radiotherapy 1986 Cisplatin 1855 Carboplatin 1559 Gemcitabine 1454 Paclitaxel 1320 Bevacizumab 1318 pembrolizumab 1236 Docetaxel 1227 Oxaliplatin 1184 Capecitabine 1176 Fluorouracil 1083 Dexamethasone 978 Magnetic Resonance Spectroscopy 969 Nivolumab 936 Rituximab 929 Drug Therapy 914 Surveys and Questionnaires 898 Doxorubicin 845 Etoposide 843 Radiosurgery 815 Blood Specimen Collection 815 Irinotecan 784 Cytarabine 743 fludarabine 726 Leucovorin 684 Surgical Procedures, Operative 639 Lenalidomide 618 Biopsy 594 fludarabine phosphate 569

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Intrauterine Devices × Clear all

NCT07028242 2025-06-19

ULTRA-SAFE

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Not yet recruiting

Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡